Literature DB >> 2562101

Natural history and prognostic factors of primary hepatocellular carcinoma: study of 70 untreated patients.

U B Kim, C J Doo, S H Baek, J H Kim, H B Lee, S K Park, J H Byun.   

Abstract

We carried out a study of the clinical courses of 70 untreated patients with primary hepatocellular carcinoma (HCC) in order to evaluate their survival period and the prognostic factors. The median survival was two months. We evaluated ten variables of biochemical parameters and findings of hepatic scintigraphy. Among them, six variables were chosen by univariate analysis. They were serum bilirubin (cut-off value 3.0 mg/dl), alkaline phosphatase (150 IU/ml), aspartate aminotransferase (AST) (200 IU/ml), alanine aminotransferase (ALT) (50 IU/ml), reticuloendothelial (RES) dysfunction (grade 1) and multiplicity of space occupying lesions (SOL). Multivariate analysis identified three variables. The RES dysfunction and multiplicity of SOL by hepatic scintigraphy and bilirubin were considered as important prognostic factors. We found that the functional reservoir of the underlying liver and multiplicity of the origin of the tumor were the most important prognostic factors.

Entities:  

Mesh:

Year:  1989        PMID: 2562101      PMCID: PMC4534990          DOI: 10.3904/kjim.1989.4.2.136

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  12 in total

1.  Clinicopathologic features of encapsulated hepatocellular carcinoma: a study of 26 cases.

Authors:  K Okuda; H Musha; Y Nakajima; Y Kubo; Y Shimokawa; Y Nagasaki; Y Sawa; S Jinnouchi; T Kaneko; H Obata; T Hisamitsu; Y Motoike; N Okazaki; M Kojiro; K Sakamoto; T Nakashima
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

Review 2.  NIH conference. Hepatocellular carcinoma.

Authors:  A M Di Bisceglie; V K Rustgi; J H Hoofnagle; G M Dusheiko; M T Lotze
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

3.  The significance of the liver-spleen uptake ration in liver scannning.

Authors:  G A Wilson; J W Keyes
Journal:  J Nucl Med       Date:  1974-07       Impact factor: 10.057

4.  Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification.

Authors:  K Okuda; R L Peters; I W Simson
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

5.  Small hepatocellular carcinoma--a clinicopathological study in thirteen patients.

Authors:  D S Chen; J C Sheu; J L Sung; M Y Lai; C S Lee; C T Su; Y M Tsang; S W How; T H Wang; J Y Yu; T H Yang; C Y Wang; C Y Hsu
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

6.  Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC.

Authors:  H C Hsu; J C Sheu; Y H Lin; D S Chen; C S Lee; L Y Hwang; R P Beasley
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

7.  Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients.

Authors:  R T Chlebowski; M Tong; J Weissman; J B Block; K P Ramming; J M Weiner; J R Bateman; J S Chlebowski
Journal:  Cancer       Date:  1984-06-15       Impact factor: 6.860

8.  A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients.

Authors:  A Primack; C L Vogel; S K Kyalwazi; J L Ziegler; R Simon; P P Anthony
Journal:  Cancer       Date:  1975-05       Impact factor: 6.860

9.  Fibrolamellar hepatocellular carcinoma.

Authors:  A C Friedman; J E Lichtenstein; Z Goodman; E K Fishman; S S Siegelman; A H Dachman
Journal:  Radiology       Date:  1985-12       Impact factor: 11.105

10.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients.

Authors:  K Okuda; T Ohtsuki; H Obata; M Tomimatsu; N Okazaki; H Hasegawa; Y Nakajima; K Ohnishi
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

View more
  2 in total

1.  Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma.

Authors:  Leung Li; Stephen L Chan; Frankie Mo; Edwin P Hui; Jane Koh; Allen K C Chan; Nelson L S Tang; Kit F Lee; Paul B S Lai; Simon C H Yu; Winnie Yeo
Journal:  Cancer Manag Res       Date:  2019-04-04       Impact factor: 3.989

2.  Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors.

Authors:  Ahmed Abdelmabood Zeeneldin; Salem Eid Salem; Amira Diaa Darwish; Mosaad Mahmoud El-Gammal; Marwa Mahmoud Hussein; Mohamed Saadeldin
Journal:  J Hepatocell Carcinoma       Date:  2015-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.